Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Collaboration and Partnerships

Sponsored by

Back to Results


Winner

Travel with IBD

by Crohn’s & Colitis UK and Takeda with support from Aurora Healthcare Communications


Summary of work

Travel for people living with Inflammatory Bowel Disease (IBD) can be highly stressful. Takeda UK and the patient advocacy group Crohn’s & Colitis UK were working separately to help improve the day-to-day experience for those living with IBD.

Both parties quickly realised the opportunity for true collaboration and partnership to maximise their individual efforts. Travel with IBD mobilised the travel industry to take key actions that would make a real difference to people living with IBD.

The aim was for widespread adoption of accessible toilet signage across the UK’s 27 main travel hubs (airports, rail stations, service stations) and to raise public awareness that not every disability is visible.

The challenge was to motivate significant numbers of people to email travel hub bosses, calling for change.

A successful national launch of survey results to media gained public attention. The results of the initiative speak for themselves: members of the public sent 50,464 campaign emails and 15 travel hubs have committed to adopting accessible toilet signage to date.

The campaign continues to scale with training resources provided to travel hubs and has also expanded to Ireland. Furthermore, the increasing use of these new signs is raising awareness of different kinds of disabilities amongst the general population.

Judges' comments

Travel with IBD demonstrated extensive national partnerships with stakeholders, and drove a change in the marketplace. It was a well-executed strategy that was inspired by a real patient need and, most importantly, it made a tangible difference.


Highly commended

Hepatitis C Testing in Community Pharmacies: A Ground-Breaking Partnership Pilot Project - by London Joint Working Group on Substance Use and Hepatitis C with support from Principle Consulting and MSD


Finalists

HS Online - by AbbVie with support from Biosector 2, a Syneos Health™ Company

Act on PAH: Improve Patient Outcomes with Early Diagnosis - by Actelion Pharmaceuticals UK Ltd with support from NexGen Healthcare Communications

IBD Registry Industry Working Group - by British Society of Gastroenterology (BSG) with support from Dovetail


Key dates

Entry deadline 29 August 2019
Extended entry deadline 5 September 2019*
*additional fee applies
Judging day 26 September 2019
Company/Team Interviews 9 October 2019
PMEA Event 27 November 2019